212 related articles for article (PubMed ID: 17241858)
1. Chronic intestinal pseudo-obstruction due to buserelin-induced formation of anti-GnRH antibodies.
Ohlsson B; Veress B; Janciauskiene S; Montgomery A; Haglund M; Wallmark A
Gastroenterology; 2007 Jan; 132(1):45-51. PubMed ID: 17241858
[TBL] [Abstract][Full Text] [Related]
2. Depletion of enteric gonadotropin-releasing hormone is found in a few patients suffering from severe gastrointestinal dysmotility.
Hammar O; Ohlsson B; Veress B; Alm R; Fredrikson GN; Montgomery A
Scand J Gastroenterol; 2012 Oct; 47(10):1165-73. PubMed ID: 22835010
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies and gastrointestinal symptoms in infertile women in relation to in vitro fertilization.
Hammar O; Roth B; Bengtsson M; Mandl T; Ohlsson B
BMC Pregnancy Childbirth; 2013 Nov; 13():201. PubMed ID: 24191889
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone analog buserelin causes neuronal loss in rat gastrointestinal tract.
Sand E; Voss U; Hammar O; Alm R; Fredrikson GN; Ohlsson B; Ekblad E
Cell Tissue Res; 2013 Mar; 351(3):521-34. PubMed ID: 23254679
[TBL] [Abstract][Full Text] [Related]
5. [Chronic intestinal pseudo-obstruction and anti-Hu syndrome: 13 years of follow-up without neoplasia].
Amiot A; Joly F; Messing B; Sokol H; Lavergne-Slove A; Delattre JY; Bouhnik Y
Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt. 1):51-5. PubMed ID: 18341976
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional consequences of buserelin-induced enteric neuropathy in rat.
Sand E; Roth B; Weström B; Bonn P; Ekblad E; Ohlsson B
BMC Gastroenterol; 2014 Dec; 14():209. PubMed ID: 25496312
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against gonadotropin-releasing hormone (GnRH) and destruction of enteric neurons in 3 patients suffering from gastrointestinal dysfunction.
Ohlsson B; Ekblad E; Veress B; Montgomery A; Janciauskiene S
BMC Gastroenterol; 2010 May; 10():48. PubMed ID: 20487533
[TBL] [Abstract][Full Text] [Related]
8. Luteinizing hormone receptors are expressed in rat myenteric neurons and mediate neuronal loss.
Sand E; Voss U; Ohlsson B; Ekblad E
Auton Neurosci; 2015 Dec; 193():104-7. PubMed ID: 26480825
[TBL] [Abstract][Full Text] [Related]
9. The role of immunohistochemistry in idiopathic chronic intestinal pseudoobstruction (CIPO): a case-control study.
Amiot A; Cazals-Hatem D; Joly F; Lavergne-Slove A; Peuchmaur M; Bouhnik Y; Bedossa P; Messing B
Am J Surg Pathol; 2009 May; 33(5):749-58. PubMed ID: 19252433
[TBL] [Abstract][Full Text] [Related]
10. [Chronic idiopathic intestinal pseudo-obstruction: visceral myopathy. Report of 4 cases].
de Pini AF; de Dávila MT; Marín A; Guastavino E; Ruiz JA; De Rosa S
Acta Gastroenterol Latinoam; 1993; 23(4):239-43. PubMed ID: 8203187
[TBL] [Abstract][Full Text] [Related]
11. Four cases with chronic intestinal pseudo-obstruction due to hollow visceral myopathy.
Arslan M; Bayraktar Y; Oksuzoglu G; Ozdemir A; Sokmensuer C; Yagmurdur MC; Soylu AR; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1999; 46(25):349-52. PubMed ID: 10228819
[TBL] [Abstract][Full Text] [Related]
12. Severe gastrointestinal dysmotility developed after treatment with gonadotropin-releasing hormone analogs.
Cordeddu L; Bergvall M; Sand E; Roth B; Papadaki E; Li L; D'Amato M; Ohlsson B
Scand J Gastroenterol; 2015 Mar; 50(3):291-9. PubMed ID: 25592315
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic intestinal pseudo-obstruction as the presenting feature of small-cell lung cancer.
Colombel JF; Parent M; Lescut D; Cortot A; Guillemot F; Plane C; Bonnière P; Lecomte-Houcke M; Paris JC
Gastroenterol Clin Biol; 1988 Apr; 12(4):394-6. PubMed ID: 2838368
[TBL] [Abstract][Full Text] [Related]
14. [Chronic intestinal pseudo-obstruction: pathogenesis, diagnosis and therapy].
Keller J; Layer P
Z Gastroenterol; 2002 Feb; 40(2):85-95. PubMed ID: 11857104
[TBL] [Abstract][Full Text] [Related]
15. Chronic idiopathic intestinal pseudo-obstruction caused by a degenerative disorder of the myenteric plexus: the use of Smith's method to define the neuropathology.
Schuffler MD; Jonak Z
Gastroenterology; 1982 Mar; 82(3):476-86. PubMed ID: 6172315
[TBL] [Abstract][Full Text] [Related]
16. Equine myenteric ganglionitis: a case of chronic intestinal pseudo-obstruction.
Burns GA; Karcher LF; Cummings JF
Cornell Vet; 1990 Jan; 80(1):53-63. PubMed ID: 2403425
[TBL] [Abstract][Full Text] [Related]
17. Diffuse lymphoplasmacytic infiltration of the small intestine with damage to nerve plexus. A cause of intestinal pseudo-obstruction.
Arista-Nasr J; González-Romo M; Keirns C; Larriva-Sahd J
Arch Pathol Lab Med; 1993 Aug; 117(8):812-9. PubMed ID: 8343045
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment and prognosis of chronic intestinal pseudo-obstruction in children.
Kim HY; Kim JH; Jung SE; Lee SC; Park KW; Kim WK
J Pediatr Surg; 2005 Nov; 40(11):1753-9. PubMed ID: 16291165
[TBL] [Abstract][Full Text] [Related]
19. Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility.
Lindberg G; Törnblom H; Iwarzon M; Nyberg B; Martin JE; Veress B
Gut; 2009 Aug; 58(8):1084-90. PubMed ID: 19136514
[TBL] [Abstract][Full Text] [Related]
20. Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileum.
Sand E; Linninge C; Lozinska L; Egecioglu E; Roth B; Molin G; Weström B; Ekblad E; Ohlsson B
BMC Res Notes; 2015 Dec; 8():824. PubMed ID: 26710832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
